Skip to main content
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Spotlight Presentation: Advancing Immunotherapy Programs with Meso Scale Discovery Biomarker Assays
    MSD biomarker assays are enabling development of immunotherapies and enhancing pre-clinical and clin ...
  1. Translational Immunology
    • Translational Immunology
    Clinical Development topic: Start with the End Goal in Mind: Efficiency in Creating Methods for Bioanalytical Endpoints  in ADA, PK, and PD Assays
    Critical reagent risk mitigation strategies Potential improvements in efficiency for preclinical and ...
  2. Clinical Development
    • Clinical Development
    Project Optimus – The impact on protocol design and requirements
    FDA on going design requirements Applications to C> Global impact Cohort management
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Afternoon Refreshments
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Evening Drinks Reception
  3. Immune Regulation
    • Immune Regulation
    Immune homeostasis through strong interplay between innate and adaptive system Dysregulation of the ...
  4. Clinical Development
    • Clinical Development
    When is project Optimus a concussive approach? How to assess and determine contribution of component ...
  5. Translational Immunology
    • Translational Immunology
    Does IL-10’s in vivo anti-inflammatory function translate to humans? Does IL-10’s in vivo adaptive s ...
  6. Immunogenicity
    • Immunogenicity
    Is it possible to down-regulate immune responses to prevent production of anti-drug antibodies? Can ...
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Networking Lunch
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Morning Refreshments
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    1-2-1 Meetings / Networking Break
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    1-2-1 Meetings / Networking Break
  7. Immune Regulation
    • Immune Regulation
    Risks of side effects caused by dysregulated immune system in drug development Potential risks of im ...
  8. Clinical Development
    • Clinical Development
    How will targeting the tumor microenvironment open new avenues for drug development? What does the s ...
  9. Translational Immunology
    • Translational Immunology
    What is the role of multi-omics in identifying biomarkers for disease diagnosis, prognosis, and trea ...
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Opening Address & Keynote Presentation: Navigating the Drug Development Pathway in Immunotherapies
    Drug development in immunotherapies is rapidly evolving with multiple new guidances from the FDA and ...
    • Immunogenicity
    • Translational Immunology
    • Clinical Development
    • Immune Regulation
    Registration